AR and prostate neoplasm: Although AR binds to the ERBB2 locus, future investigation to assess the role of ligand-stimulated HER2 signaling in prostate tumor tissues will more clearly define the biological basis for HER2 activation beyond ERBB2 expression and its role in promoting prostate tumor cell growth and survival in an AR activity–low state.